Consumer medicine information

MenQuadfi 40 mcg/0.5 mL Solution for injection

Meningococcal polysaccharide conjugate A, C, Y and W-135 vaccine

BRAND INFORMATION

Brand name

MenQuadfi

Active ingredient

Meningococcal polysaccharide conjugate A, C, Y and W-135 vaccine

Schedule

S4

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using MenQuadfi 40 mcg/0.5 mL Solution for injection.

1. Why am I using MenQuadfi?


MenQuadfi is a vaccine. It is used to help protect you or your child against infections caused by a bacteria (germs) called “Neisseria meningitides” types A, C, W and Y. MenQuadfi can be given to children (12 months of age and above), adolescents, adults and the elderly.
For more information, see Section 1. Why am I using MenQuadfi? in the full CMI.

2. What should I know before I use MenQuadfi?


Do not use if you have ever had an allergic reaction to MenQuadfi or any of the ingredients listed at the end of the CMI.
Talk to your doctor, nurse or pharmacist if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding.
For more information, see Section 2. What should I know before I use MenQuadfi? in the full CMI.

3. What if I am taking other medicines?


Some medicines may interfere with MenQuadfi and may affect how it works. Tell your doctor nurse or pharmacist if you are taking, have recently taken or might take any other vaccines or medicines, including medicines obtained without a prescription.
For more information, see Section 3. What if I am taking other medicines? in the full CMI.

4. How do I use MenQuadfi?


MenQuadfi is given by your doctor, nurse or pharmacist.
More instructions can be found in Section 4. How do I use MenQuadfi? in the full CMI.

5. What should I know after using MenQuadfi?

Things you should do
Call your doctor, nurse or pharmacist straight away if you:
  • notice signs of allergic reaction which include rash, itching, difficulty breathing, shortness of breath or swelling of the face, lips, throat or tongue.

Driving or using machines
  • MenQuadfi is not likely to affect your ability to drive or use machines. However, do not drive or use any machines if you are feeling unwell.
Looking after your medicineMenQuadfi is usually stored in the doctor's surgery or clinic, or at a pharmacy. However, if you need to store MenQuadfi: keep in the fridge between 2-8°C. Do not freeze.

For more information, see Section 5. What should I know after using MenQuadfi? in the full CMI.

6. Are there any side effects?


Serious side effects can include allergic reactions. See your doctor immediately if you notice this. Common side effects in children (2 years of age and older), adolescents, adults and elderly include pain, redness, or swelling at the injection site, muscle pain, headache, generally feeling unwell and fever. In children 12-23 months of age, common side effects include tenderness, redness or swelling at the injection site, feeling irritable, crying, loss of appetite, feeling drowsy, fever, vomiting and diarrhoea.
For more information, including what to do if you have any side effects, see Section 6. Are there any side effects? in the full CMI.

BRAND INFORMATION

Brand name

MenQuadfi

Active ingredient

Meningococcal polysaccharide conjugate A, C, Y and W-135 vaccine

Schedule

S4

 

1 Name of Medicine

Meningococcal (groups A, C, Y, W) polysaccharide tetanus toxoid conjugate vaccine.

2 Qualitative and Quantitative Composition

Each 0.5 mL dose of vaccine contains:
Meningococcal polysaccharide* Group A 10.0 microgram/dose;
Meningococcal polysaccharide* Group C 10.0 microgram/dose;
Meningococcal polysaccharide* Group Y 10.0 microgram/dose;
Meningococcal polysaccharide* Group W-135 10.0 microgram/dose.
* Each of the four polysaccharides is conjugated to tetanus toxoid (approximately 55 microgram/dose).
MenQuadfi is a sterile solution of Neisseria meningitidis (N. meningitidis) purified capsular polysaccharides of groups A, C, W-135, and Y, individually conjugated to tetanus toxoid protein prepared from cultures of Clostridium tetani. No preservative or adjuvant is added during manufacture.
For the full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

Solution for injection.
MenQuadfi is a clear, colourless, sterile, preservative-free solution.

4 Clinical Particulars

4.9 Overdose

For general advice on overdose management, contact the Poisons Information Centre, telephone number 13 11 26 (Australia).

5 Pharmacological Properties

5.3 Preclinical Safety Data

Genotoxicity. MenQuadfi has not been evaluated for genotoxic potential.
Carcinogenicity. MenQuadfi has not been evaluated for carcinogenic potential.

6 Pharmaceutical Particulars

6.7 Physicochemical Properties

No data available.

7 Medicine Schedule (Poisons Standard)

S4 Prescription Only Medicine.

Summary Table of Changes

https://stagingapi.mims.com/au/public/v2/images/fulltablegif/MNQUFIST.gif